title: Varicella vaccination: where do we go from here?
abstract: Although meager knowledge of the virus raises serious safety questions, the risk of death from varicella in immunocompromised children justifies further trials. In the meantime, passive immunization is a safe and relatively effective alternative.
mesh_terms: D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D002644:Chickenpox / Q000517:prevention & control*; D002648:Child; D006562:Herpes Zoster / Q000517:prevention & control*; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage; D007114:Immunization; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D007223:Infant; D007938:Leukemia / Q000188:drug therapy; D008875:Middle Aged; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000914:Antibodies, Viral; D007106:Immune Sera; D014765:Viral Vaccines